Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.

Saved in:
Bibliographic Details
Title: Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.
Authors: Koopman LA; Genmab (Netherlands) Utrecht Netherlands., Alemdehy F; Genmab (Netherlands) Utrecht Netherlands., de Poot SAH; Genmab (Netherlands) Utrecht Netherlands., Paauwe M; Genmab (Netherlands) Utrecht Netherlands., Wang W; Genmab (Netherlands) Utrecht Netherlands., Epstein KR; University of Pennsylvania Philadelphia United States., van den Brink EN; Genmab (Netherlands) Utrecht Netherlands., Gorlani A; Genmab (Netherlands) Utrecht Netherlands., Verzijl D; Genmab (Netherlands) Utrecht Netherlands., Brandhorst M; Genmab (Netherlands) Utrecht Netherlands., Franken P; Genmab (Netherlands) Utrecht Netherlands., Smits-de Vries L; Genmab (Netherlands) Utrecht Netherlands., Gielen E; Genmab (Netherlands) Utrecht Netherlands., Plantinga TS; Genmab (Netherlands) Utrecht Netherlands., Houtkamp M; Genmab (Netherlands) Utrecht Netherlands., Engelberts PJ; Genmab (Netherlands) Utrecht Netherlands., Lihme Egerod F; Genmab (Denmark) Copenhagen Denmark., Thalhauser CJ; Genmab (United States) Plainsboro, New Jersey United States., Bosgra S; Genmab (Netherlands) Utrecht Netherlands., Gitto SB; University of Pennsylvania Philadelphia, PA United States., Powell DJ; University of Pennsylvania Philadelphia, PA United States., Gamse JT; Genmab (United States) Plainsboro, NJ United States., Overdijk MB; Genmab (Netherlands) Utrecht, utrecht Netherlands., Breij ECW; Genmab (Netherlands) Utrecht Netherlands.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 30. Date of Electronic Publication: 2026 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42374845
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koopman+LA%22">Koopman LA</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Alemdehy+F%22">Alemdehy F</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Poot+SAH%22">de Poot SAH</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Paauwe+M%22">Paauwe M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Epstein+KR%22">Epstein KR</searchLink>; University of Pennsylvania Philadelphia United States.<br /><searchLink fieldCode="AU" term="%22van+den+Brink+EN%22">van den Brink EN</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gorlani+A%22">Gorlani A</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Verzijl+D%22">Verzijl D</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Brandhorst+M%22">Brandhorst M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Franken+P%22">Franken P</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Smits-de+Vries+L%22">Smits-de Vries L</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gielen+E%22">Gielen E</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Plantinga+TS%22">Plantinga TS</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Houtkamp+M%22">Houtkamp M</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Engelberts+PJ%22">Engelberts PJ</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Lihme+Egerod+F%22">Lihme Egerod F</searchLink>; Genmab (Denmark) Copenhagen Denmark.<br /><searchLink fieldCode="AU" term="%22Thalhauser+CJ%22">Thalhauser CJ</searchLink>; Genmab (United States) Plainsboro, New Jersey United States.<br /><searchLink fieldCode="AU" term="%22Bosgra+S%22">Bosgra S</searchLink>; Genmab (Netherlands) Utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Gitto+SB%22">Gitto SB</searchLink>; University of Pennsylvania Philadelphia, PA United States.<br /><searchLink fieldCode="AU" term="%22Powell+DJ%22">Powell DJ</searchLink>; University of Pennsylvania Philadelphia, PA United States.<br /><searchLink fieldCode="AU" term="%22Gamse+JT%22">Gamse JT</searchLink>; Genmab (United States) Plainsboro, NJ United States.<br /><searchLink fieldCode="AU" term="%22Overdijk+MB%22">Overdijk MB</searchLink>; Genmab (Netherlands) Utrecht, utrecht Netherlands.<br /><searchLink fieldCode="AU" term="%22Breij+ECW%22">Breij ECW</searchLink>; Genmab (Netherlands) Utrecht Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Jun 30. <i>Date of Electronic Publication: </i>2026 Jun 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42374845
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-26-0054
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koopman LA
      – PersonEntity:
          Name:
            NameFull: Alemdehy F
      – PersonEntity:
          Name:
            NameFull: de Poot SAH
      – PersonEntity:
          Name:
            NameFull: Paauwe M
      – PersonEntity:
          Name:
            NameFull: Wang W
      – PersonEntity:
          Name:
            NameFull: Epstein KR
      – PersonEntity:
          Name:
            NameFull: van den Brink EN
      – PersonEntity:
          Name:
            NameFull: Gorlani A
      – PersonEntity:
          Name:
            NameFull: Verzijl D
      – PersonEntity:
          Name:
            NameFull: Brandhorst M
      – PersonEntity:
          Name:
            NameFull: Franken P
      – PersonEntity:
          Name:
            NameFull: Smits-de Vries L
      – PersonEntity:
          Name:
            NameFull: Gielen E
      – PersonEntity:
          Name:
            NameFull: Plantinga TS
      – PersonEntity:
          Name:
            NameFull: Houtkamp M
      – PersonEntity:
          Name:
            NameFull: Engelberts PJ
      – PersonEntity:
          Name:
            NameFull: Lihme Egerod F
      – PersonEntity:
          Name:
            NameFull: Thalhauser CJ
      – PersonEntity:
          Name:
            NameFull: Bosgra S
      – PersonEntity:
          Name:
            NameFull: Gitto SB
      – PersonEntity:
          Name:
            NameFull: Powell DJ
      – PersonEntity:
          Name:
            NameFull: Gamse JT
      – PersonEntity:
          Name:
            NameFull: Overdijk MB
      – PersonEntity:
          Name:
            NameFull: Breij ECW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 06
              Text: 2026 Jun 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1